Beijing Centre Biology
Beijing Centre Biology is a company specializing in researching, developing, manufacturing and selling animal health care products
About Beijing Centre Biology
Founded in 1999, Beijing Centre Biology Co., Ltd. is a specialized group company focused on the animal health care sector. The firm is engaged in the research, development, manufacturing, and sale of a broad portfolio of products. Its offerings are diverse, encompassing natural herbal products, vaccines, chemical drugs, feed additives, and pet food. The company holds numerous quality certifications, including GMP, GMP+, ISO 9001, and ISO 14001, and states that its products can meet international standards such as USP, EP, and BP.
The company's business model revolves around producing and distributing animal health products to a wide range of clients. These clients include poultry and livestock breeding bases for export, large-scale breeding enterprises, and over a thousand wholesalers within China. Demonstrating a global reach, the company exports its products to more than 50 countries across Europe, South America, Asia, and Africa. Its product lines are segmented for both farm animals and pets. For farm animals, it offers vaccines, herbal products, and chemical medicines in various forms like injections, powders, and oral solutions. For pets, the portfolio includes nutrition, prescription foods, and complete pet food for dogs and cats.
Beijing Centre Biology operates multiple branch companies, including Aether Centre Biology Co., Ltd., Centre (Inner Mongolia) Biology Co., Ltd., and Wepel Petcare Co., Ltd. Its manufacturing capabilities are substantial, with a factory covering 82,000 square meters and housing 35 GMP production lines. The company employs over 700 people, with more than 63% being technical professionals. Its research and development team consists of 68 staff members with varied expertise in fields like Chinese traditional veterinary medicine, biotechnology, and animal nutrition. The company has received $42.5M in funding from investors including Axiom Asia Private Capital, LYFE Capital, Tengye Ventures, Cowin Capital, and Qiming Venture Partners.
Source: Dealroom company dataNews
Open roles
Beijing Centre Biology in the Changping District ecosystem
The Beijing Centre Biology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Centre Biology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Centre Biology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

